The Palmer Foundation

‘Going on offense’: South Dakota implements first statewide hydroxychloroquine trial in fight against coronavirus

Source: Washington Examiner

video

Watch the excerpt: South Dakota will be the first U.S. state to hold a statewide trial for hydroxychloroquine as a possible treatment of the coronavirus.

Gov. Kristi Noem announced on Monday that the state health department and every major hospital would take part in a clinical trial to treat COVID-19 patients and those who have been exposed to individuals who tested positive for the coronavirus. The trial, which will be led by Sanford Health, was given approval by federal authorities to be the first statewide trial of the drug.

“We are going to be the first state in the nation to run a statewide clinical trial on hydroxychloroquine. It will be used to fight COVID-19, and the team behind me, Sanford Health, has helped lead this effort,” Noem said.

Studies and global announcements

new

COVID-19 survivors

Global hydroxychloroquine timeline of events

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories

Explore more

Dr. Harvey Risch: Hydroxychloroquine, Ivermectin, and Other Therapeutics Highly Effective in Early COVID Treatment

I’ve railed against this in the media that we are a part of, and the way that the propaganda reacts to this is, “Ignore it. Ignore all of this.” I’m saying this now because the general public has to be the one that gets angry. The general public should be furious at the way people have been treated in the country by suppression of these drugs, by that kind of website that suppresses the ability of doctors to practice medicine.

Read More »
30/11/2021

A Judge Stands up to a Hospital: “Step Aside” and Give a Dying Man Ivermectin

The judge’s finest moment may have been when he dashed the most glaring myth about ivermectin—that it is not safe, despite decades of use that shows otherwise. Noting that all drugs have side effects, Judge Fullerton listed ivermectin’s effects from a government website.
“(N)umber one, generally well tolerated; number two, dizziness; number three, pruritus; number four, nausea/diarrhea. These are the side effects for the dosage that’s being asked to be administered,” he said. “The risks of these side effects are so minimal that Mr. Ng’s current situation outweighs that risk by one-hundredfold.”

Read More »
24/11/2021
Share on facebook
Facebook
Share on twitter
Twitter

Copyright 2020 © The Palmer Foundation